In spite of the lack of consensus about the markers for ovarian CSC, several groups including our own have reported the role of CD44+ ovarian cancer cells in tumor initiation and chemoresistance [8, 20–24] – a role that has been ascribed to CSC. This evidence concerns the gene CD44 and ovarian cancer.